Investigation of Low-intensity Focused Ultrasound Pressure

NCT ID: NCT06343883

Last Updated: 2025-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-16

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigating the relationship between input pressure of low-intensity focused ultrasound and an evoked potential in both eeg and fMRI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study aims to determine safety and efficacy of variable pressures of low-intensity focused ultrasound using an electrical stimulation to create a somatosensory evoked potential and record eeg and fMRI outcome measures. A primary safety study will be conducted prior to 'full scale' data collection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Somatic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary cohort (safety) will be collected prior to full study collection. Primary collection will involve highest pressure application and follow-up safety scans (MRI) to be reviewed by a Neuroradiologist. Once cleared - parallel design will be utilized for eeg and fMRI cohorts. Both cohorts will receive 3 LIFU pressures randomized over 3 study visits. Electrical stimulations will be applied pre and post LIFU administration to induce somatosensory evoked potentials (SEPs).
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

No masking, no sham. All subjects will receive all conditions, all of which are active.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Safety Check - high pressure application

Small cohort to be collected prior to other study cohorts. Highest of 3 pressures of interest will be applied to the S1 (somatosensory cortex) with a follow-up MRI conducted 24-72 hours post.

Group Type EXPERIMENTAL

low-intensity focused ultrasound - high pressure

Intervention Type DEVICE

low-intensity focused ultrasound applied to the S1.

EEG

Electrical stimulation utilized to generate SEPs, performed pre and post LIFU application. One of three LIFU pressures will be applied. One per study visit (3), randomized order. EEG collected throughout visit (outcome measure).

Group Type EXPERIMENTAL

low-intensity focused ultrasound - low pressure

Intervention Type DEVICE

low-intensity focused ultrasound applied to the S1.

low-intensity focused ultrasound - medium pressure

Intervention Type DEVICE

low-intensity focused ultrasound applied to the S1.

low-intensity focused ultrasound - high pressure

Intervention Type DEVICE

low-intensity focused ultrasound applied to the S1.

fMRI

Electrical stimulation utilized to generate SEPs, performed pre and post LIFU application. One of three LIFU pressures will be applied. One per study visit (3), randomized order. fMRI collected throughout visit (outcome measure).

Group Type EXPERIMENTAL

low-intensity focused ultrasound - low pressure

Intervention Type DEVICE

low-intensity focused ultrasound applied to the S1.

low-intensity focused ultrasound - medium pressure

Intervention Type DEVICE

low-intensity focused ultrasound applied to the S1.

low-intensity focused ultrasound - high pressure

Intervention Type DEVICE

low-intensity focused ultrasound applied to the S1.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

low-intensity focused ultrasound - low pressure

low-intensity focused ultrasound applied to the S1.

Intervention Type DEVICE

low-intensity focused ultrasound - medium pressure

low-intensity focused ultrasound applied to the S1.

Intervention Type DEVICE

low-intensity focused ultrasound - high pressure

low-intensity focused ultrasound applied to the S1.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Understand and speak English

Exclusion Criteria

1. Claustrophobia (scanning environment may be uncomfortable).
2. Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
3. Contraindications to CT: pregnancy
4. Active medical disorder or treatment with potential CNS effects (e.g. Alzheimer's)
5. History of neurologic disorder. (e.g. Parkinson's, Epilepsy, or Essential Tremor)
6. History of head injury resulting in loss of consciousness for \>10 minutes.
7. History of alcohol or drug dependence (through self-report).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Virginia Polytechnic Institute and State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wynn Legon

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24-353

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

tFUS Imaging & LIFU
NCT07222865 WITHDRAWN NA